Showing results (251-260 of 326) with videos related to
Sort By:
Pageof 33
Dalton Transactions (Cambridge, England : 2003)|July 31, 2015
Coordination polymers from a highly flexible alkyldiamine-derived ligand: structure, magnetism and gas adsorption studiesChris S Hawes, Nicholas F Chilton, Boujemaa Moubaraki, et al.Parasites & Vectors|May 21, 2020
Equid infective Theileria cluster in distinct 18S rRNA gene clades comprising multiple taxa with unusually broad mammalian host rangesRichard P Bishop, Lowell S Kappmeyer, Cynthia K Onzere, et al.Antimicrobial Agents and Chemotherapy|July 22, 2009
Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potentialO Nicolas Schwint, Massaro W Ueti, Guy H Palmer, et al.Plos One|June 4, 2015
Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced NeurotoxicityJenny Dworzak, Benoît Renvoisé, Johnny Habchi, et al.Infection and Immunity|May 23, 2006
Differential expression and sequence conservation of the Anaplasma marginale msp2 gene superfamily outer membrane proteinsSusan M Noh, Kelly A Brayton, Donald P Knowles, et al.Journal of Dental Research|February 27, 2016
Osteoprotective Effects of Estrogen in the Maxillary Bone Depend on ERαS Macari, L Ajay Sharma, A Wyatt, et al.Experimental Parasitology|August 14, 2002
Sarcocystis neurona: parasitemia in a severe combined immunodeficient (SCID) horse fed sporocystsMaureen T Long, Melissa T Mines, Donald P Knowles, et al.Australian Veterinary Journal|May 20, 1999
Comparison of a competitive inhibition ELISA and the card agglutination test for detection of antibodies to Anaplasma marginale and Anaplasma centrale in cattleJ B Molloy, P M Bowles, D P Knowles, et al.Cancer Research|November 15, 1988
Improved antitumor effects of immunotoxins prepared with deglycosylated ricin A-chain and hindered disulfide linkagesP E Thorpe, P M Wallace, P P Knowles, et al.Journal of the National Cancer Institute|November 1, 1987
Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutantsP E Thorpe, D C Blakey, A N Brown, et al.Pageof 33